CDK4/6 - Globe Thesis - Globe Thesis

Keyword [CDK4/6] Result: 41 - 60 \| Page: 3 of 4
41.	Therapeutic Effect And Mechanism Of CDK4/6 Inhibitor Combined With Pd-1 Monoclonal Antibody In Mouse Ovarian Cancer
42.	Investigation On The Effect Of HPV Infection On Anti-cervical Cancer Activity Of LEE011 And Its Mechanism
43.	The Mechanism Of Drug Resistance Of CDK4/6 Inhibitors In The Treatment Of Breast Cancer
44.	The Antitumor Mechanism Of PARP Inhibitor Combined With CDK4/6 Inhibitor In P53-wildtype Gastrointestinal Cancer
45.	Study On The Value And Strategy Of CDK4/6 Inhibitors In Ovarian Cancer
46.	The Function And Mechanism Of Cyclin-dependent Kinase 4/6 Mediated Tumor Immunity
47.	Cancer/Testis Antigen MAGEC2 Promotes Resistance To CDK4/6 Inhibitors In HR+/HER2- Breast Cancer By Activating PI3K/AKT/mTOR Pathway
48.	Design,Synthesis And Biological Activity Evaluation Of Kinase RET And CDK4/6 Inhibitors From Two Bioactive Scaffolds
49.	Experimental Study Of The Mechanism Of CDK4/6 Inhibitor SHR6390 Inhibiting The Proliferation Of Cervical Cancer Cells
50.	The Synthesis Of Novel Based Piperazine Benzamide Derivatives And Study On Cycle Proliferation Inhibition In Glioma
51.	To Explore The Mechanism Of CDK4/6 Inhibitor Palbociclib Involved In(RB+/CCNE1-)ER+ Positive Breast Cancer Resistance Through Autophagy Activated By MAPK Pathway
52.	Targeting MEK And CDK4/6 Induces Cell Cycle Arrest In KRAS-mutant Gastric Cancer Cells
53.	Study Of Drug Resistance Genes In CDK4/6 Inhibitor-resistant Luminal-type Breast Cancer
54.	Mechanisms Of Ribociclib-induced Cardiotoxicity By Targeting The HERG Channel
55.	CDK4/6 Inhibitors Combined With Endocrine Therapy For Advanced Breast Cancer Clinical Study On Efficacy And Safety
56.	Effects Of CDK4/6 Inhibitor Abemaciclib Combined With Cisplatin On Biological Behavior Of Human Gastric Cancer Cells
57.	Monitoring The Therapeutic Response To Anti-Tumor Drugs Targeting Cyclin-Dependent Kinase CDK4/6 In Breast Cancer By Molecular Imaging
58.	Expression Of CDK4/6 And Pathological Characteristics And Survival Prognosis Of Patients With Adenocarcinoma Of Esophagogastric Junction After Operation
59.	CDK4/6 Inhibitor Reverses Acquired Drug Resistance Of PARP Inhibitor In Ovarian Epithelial Carcinoma By Restoring Homologous Recombination Deficiency
60.	Synergistic Induction Of Autophagy In KRAS Mutant Gastric Cancer Cells By Targeting CDK4/6 And MEK
<<First <Prev Next> Last>> Jump to